Potassium Binders
High-yield Verified · Oct 2026Potassium Binders are a class of medications used for sodium polystyrene sulfonate for hyperkalemia.
Medical view → mechanisms, drug comparisons and Step 1 pharmacology
Potassium binders take potassium out of the body through the gut, and they do it slowly. Calcium and the shift drugs handle the emergency; the binder does the removal.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 Removing potassium through the gut
Potassium binders lower serum potassium by removing potassium through the gut. None of them is absorbed. Each binds potassium in the lumen of the gastrointestinal tract, the free potassium in the lumen falls, and fecal potassium excretion rises, so serum potassium comes down.
Sodium polystyrene sulfonate (SPS) is a cation-exchange resin given by mouth or as an enema. As it passes along the intestine, or is held in the colon after an enema, it releases sodium and takes up potassium, mostly in the large intestine. The exchange is limited and unpredictably variable (commonly around 33%), and it is not selective: small amounts of magnesium and calcium are lost as well.
Patiromer is a non-absorbed cation-exchange polymer with a calcium-sorbitol counterion; the WHO stem -mer marks polymers. It also binds magnesium in the colon. Sodium zirconium cyclosilicate (SZC) is a non-absorbed zirconium silicate that preferentially captures potassium in exchange for hydrogen and sodium, and it keeps a high affinity for potassium even when calcium and magnesium are present. SZC also causes a small, dose-dependent rise in serum bicarbonate, of unclear clinical significance.
02 Removal, not rescue
Hyperkalemia comes from impaired renal excretion, excess potassium intake, or drugs such as potassium-sparing diuretics and renin–angiotensin–aldosterone system inhibitors, and the risk is higher in chronic kidney disease. Treatment has three parts: stabilize the cardiac membrane with calcium, shift potassium into cells (insulin, β2 agonists, and bicarbonate in metabolic acidosis), and eliminate it from the body. The binders belong to the third step, along with diuretics and dialysis. The Electrolyte & Fluid Replacement page teaches the first two steps.
The binders’ onset is delayed. Serum potassium starts to fall about 1 hour after SZC is started and about 7 hours after the first dose of patiromer, and it keeps falling over 48 hours; with SPS, effective lowering may take hours to days. For this reason the patiromer and SZC labels state that they should not be used as emergency treatment for life-threatening hyperkalemia. The SPS label warns that SPS alone may not correct severe hyperkalemia fast enough, and that other definitive measures, including dialysis, should always be considered.
SPS is FDA-approved for hyperkalemia but is not typically the first-line treatment, and its slow onset makes it a second-line agent in emergencies. Its use has fallen because of questionable efficacy and gastrointestinal complications such as colonic necrosis.
03 Three binders, three risk profiles
SPS carries a serious warning: intestinal necrosis, which may be fatal, along with bleeding, ischemic colitis and perforation. Most of the reported cases involved sorbitol given at the same time. The FDA warned against using SPS with sorbitol in 2009, and additional sorbitol is not recommended. SPS is used only in patients with normal bowel function and is stopped if constipation develops. About a third of its sodium is delivered to the body, so it needs caution in severe heart failure, severe hypertension or marked edema. Inhaled particles have caused bronchitis and bronchopneumonia, so it is given with the patient upright.
Patiromer binds magnesium as well as potassium: hypomagnesemia was reported in 5.3% of adults in clinical studies, and serum magnesium is monitored. Constipation is its most common adverse reaction. Because it binds some other oral drugs, its label directs that other oral medications be taken at least 3 hours before or after it, unless they are shown not to interact. SPS has the same 3-hour rule, and patients with gastroparesis may need 6 hours.
SZC contains sodium and can cause edema, which was more common at higher doses. Edema is watched for in patients who should restrict sodium or are prone to fluid overload, such as those with heart failure or kidney disease. SZC transiently raises gastric pH, which changes the absorption of drugs whose solubility depends on pH, so other oral medications are generally taken at least 2 hours before or after it. Patients on hemodialysis can become hypokalemic during an acute illness, and SZC is radio-opaque on abdominal X-rays.
Patiromer and SZC are avoided in severe constipation, bowel obstruction or impaction, including abnormal post-operative bowel motility, because they may not work and may worsen the condition. SPS is contraindicated in obstructive bowel disease.
Drug names
Indications
- Sodium polystyrene sulfonate (Kionex) for hyperkalemia
- Patiromer (Veltassa) for hyperkalemia in adults and children 12 years and older; not for emergency treatment of life-threatening hyperkalemia, because its onset is delayed
- Sodium zirconium cyclosilicate (Lokelma) for hyperkalemia in adults; not for emergency treatment of life-threatening hyperkalemia, because its onset is delayed
Mechanism of action
Potassium binders are non-absorbed agents that bind potassium in the lumen of the gastrointestinal tract and increase fecal potassium excretion. Less free potassium in the lumen lowers serum potassium. Sodium polystyrene sulfonate is a cation-exchange resin that releases sodium in exchange for potassium, mostly in the large intestine; its efficiency is limited and unpredictable, and it is not selective, so magnesium and calcium are also lost. Patiromer is a cation-exchange polymer with a calcium-sorbitol counterion, and it also binds magnesium in the colon. Sodium zirconium cyclosilicate is a zirconium silicate that preferentially captures potassium in exchange for hydrogen and sodium, with a high affinity for potassium even in the presence of calcium and magnesium.
Therapeutic effects — what you'll see working
Success is a serum potassium brought into, and kept within, the target range. It is judged by repeated potassium levels, and the dose is lowered or stopped if potassium falls below the target.
- ↓ Serum potassium
- The fall is gradual: about 1 hour after SZC is started and about 7 hours after the first patiromer dose, continuing over 48 hours; SPS may take hours to days. Potassium rises again when the binder is stopped.
- ↑ Fecal potassium excretion
- Binding potassium in the gut lumen raises fecal potassium excretion, and urinary potassium excretion falls correspondingly.
Adverse effects
The binders are not absorbed, so their harms arise in the gut or from what they carry, exchange or bind: too much potassium removed, the sodium in SPS and SZC, the magnesium patiromer binds, and other oral drugs bound in the gut.
Interactions
Contraindications
The labeled contraindications are few: four for sodium polystyrene sulfonate, one (hypersensitivity) for patiromer, and none for sodium zirconium cyclosilicate. The practical limits are the bowel and time. A binder needs a working bowel, and it acts too slowly to be the emergency treatment.
When to hold
Assess before giving — these findings mean hold the dose and act.
Labs & levels
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
What are Potassium Binders used for?
How do Potassium Binders work?
What are the serious side effects of Potassium Binders?
When should a nurse hold Potassium Binders, and what safety checks apply?
What labs should be monitored with Potassium Binders?
See also
The most powerful ("high-ceiling") diuretics — they work even in kidney failure. Watch potassium, volume, and hearing.
First-line for hypertension — a milder diuretic acting further down the nephron. Remember the four metabolic highs — glucose, lipids, uric acid and calcium — and that the calcium rise comes from retention (opposite of loops).
Weak diuretics that preserve potassium instead of wasting it — the defining danger is hyperkalemia. Two mechanisms; spironolactone also lowers heart-failure mortality.
Two diuretic groups that are used mostly for something other than edema: the carbonic anhydrase inhibitors acetazolamide and methazolamide (glaucoma, altitude sickness) and the osmotic diuretic mannitol (raised intracranial or intraocular pressure). Watch for metabolic acidosis, low potassium and serious sulfonamide reactions with the first group, and for fluid overload, kidney injury and electrolyte swings with mannitol.
Tolvaptan blocks vasopressin’s V2 receptor in the kidney so the body sheds free water and serum sodium rises (Samsca, for hyponatremia), and it slows kidney decline in polycystic kidney disease (Jynarque). The two brands carry different boxed warnings: correcting sodium too fast, and serious liver injury.
Replacing potassium, magnesium, calcium, phosphate & fluids, and correcting acidosis with IV bicarbonate. IV potassium is high-alert — NEVER push it.
Sources
- Kionex (sodium polystyrene sulfonate) — FDA label: mechanism, contraindications, intestinal necrosis and sorbitol, delayed effect, hypokalemia, sodium load, aspiration, oral drug binding — FDA / DailyMed
- Veltassa (patiromer) — FDA label: mechanism, emergency limitation, hypomagnesemia, GI motility, 3-hour separation, onset — FDA / DailyMed
- Lokelma (sodium zirconium cyclosilicate) — FDA label: mechanism, emergency limitation, edema, hemodialysis, gastric pH and 2-hour separation, onset — FDA / DailyMed
- Sodium Polystyrene Sulfonate — place in therapy, sorbitol warning, sodium overload — StatPearls / NCBI Bookshelf
- Hyperkalemia — causes, stabilize–shift–eliminate management, place of the cation exchangers — StatPearls / NCBI Bookshelf
- The use of stems in the selection of INN (stem -mer) — World Health Organization
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.